Literature DB >> 30032691

Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma.

Anuhya Kommalapati1, Sri Harsha Tella1, Ronald S Go2, Gaurav Goyal2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30032691     DOI： 10.1080/10428194.2018.1492128

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Application of PD-L1 blockade in refractory histiocytic sarcoma: A case report.

Authors:  Osamu Imataki; Makiko Uemura; Haruyuki Fujita; Norimitsu Kadowaki
Journal:  Mol Clin Oncol       Date:  2022-07-15

2.  Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma.

Authors:  Shree Bose; Joanna Robles; Chad M McCall; Anand S Lagoo; Daniel S Wechsler; Gary R Schooler; David Van Mater
Journal:  Pediatr Blood Cancer       Date:  2018-09-30       Impact factor: 3.167

3.  Histiocytic Sarcoma: Clinical Features and Outcomes of Patients Treated at a Tertiary Cancer Care Center.

Authors:  Deepa Susan Joy Philip; Amitha Sherief; Geetha Narayanan; Sreejith G Nair; Jayasudha Av
Journal:  Cureus       Date:  2022-06-10

4.  Histiocytic Sarcoma Involving Cervical Vertebra: A Case Report and Review of the Literature.

Authors:  Eshagh Bahrami; Masoumeh Najafi; Amin Jahanbakhshi; Jaber Hatam; Saadat Molanaei; Patrizia Ciammella; Salvatore Cozzi
Journal:  Brain Sci       Date:  2022-07-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.